• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性类天疱疮中嗜酸性粒细胞趋化因子及其特异性受体CCR3的表达增加。

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.

作者信息

Frezzolini Alessandra, Teofoli Patrizia, Cianchini Giuseppe, Barduagni Silvia, Ruffelli Marina, Ferranti Giulio, Puddu Pietro, De Pita Ornella

机构信息

Department of Immunodermatology, Istituto Dermopatico dell'Immacolata, IDI, IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy.

出版信息

Eur J Dermatol. 2002 Jan-Feb;12(1):27-31.

PMID:11809592
Abstract

Several skin infiltrating inflammatory cells, such as eosinophils, neutrophils and activated T lymphocytes, are involved in bullous pemphigoid (BP) blister formation. The presence of CD4+ T cells able to produce IL-4 and IL-5 suggests Th2 involvement in the disease. The role of eotaxin in the recruitment of eosinophils into inflammatory sites has been recently described and the specific eotaxin receptor, CCR3, has been documented to be expressed on eosinophils, basophils, and Th2 cells. In this study, we analyzed by immunohistochemistry the expression of both eotaxin and CCR3 in lesional skin from patients with active BP (n = 10) and control subjects affected with pemphigus vulgaris (PV) (n = 3); furthermore eotaxin concentration in BP sera and blister fluids was also evaluated by enzyme-linked immunosorbent assay (ELISA), in comparison to sera from PV and normal donors (n = 10) and to suction blisters from 3 healthy volunteers. A strong immunostaining for eotaxin and CCR3 in BP skin specimens in lesional and, to a lesser extent, in perilesional skin was observed. CCR3 expression was documented on both eosinophils and T cells infiltrating skin lesions. Eotaxin serum levels were significantly higher in BP patients when compared to healthy donors (p = 0.003) and PV patients (p = 0.01). The highest eotaxin concentration was detected in BP blister fluids, in respect to both corresponding BP sera and blister fluids from normal donors (p = 0.003). These results account for the role of eotaxin in the recruitment of activated cells at inflammatory sites during BP and the expression of CCR3 on infiltrating T lymphocytes further supports the involvement of Th2 cells in the pathogenesis of BP.

摘要

多种皮肤浸润性炎症细胞,如嗜酸性粒细胞、中性粒细胞和活化的T淋巴细胞,参与了大疱性类天疱疮(BP)水疱的形成。能够产生白细胞介素-4和白细胞介素-5的CD4 + T细胞的存在提示Th2细胞参与了该疾病。嗜酸性粒细胞趋化因子在嗜酸性粒细胞募集到炎症部位中的作用最近已有描述,并且已证明特异性嗜酸性粒细胞趋化因子受体CCR3在嗜酸性粒细胞、嗜碱性粒细胞和Th2细胞上表达。在本研究中,我们通过免疫组织化学分析了活动性BP患者(n = 10)的皮损和寻常型天疱疮(PV)患者(n = 3)的皮损中嗜酸性粒细胞趋化因子和CCR3的表达;此外,还通过酶联免疫吸附测定(ELISA)评估了BP患者血清和水疱液中嗜酸性粒细胞趋化因子的浓度,并与PV患者和正常供体(n = )的血清以及3名健康志愿者的抽吸疱进行了比较。在BP皮肤标本的皮损处以及在较小程度上在皮损周围皮肤中观察到了嗜酸性粒细胞趋化因子和CCR3的强免疫染色。在浸润皮肤病变的嗜酸性粒细胞和T细胞上均记录到CCR-3表达。与健康供体(p = 0.003)和PV患者(p = 0.01)相比,BP患者的血清嗜酸性粒细胞趋化因子水平显著更高。与相应的BP血清和正常供体的水疱液相比,在BP水疱液中检测到最高的嗜酸性粒细胞趋化因子浓度(p = 0.003)。这些结果说明了嗜酸性粒细胞趋化因子在BP期间炎症部位活化细胞募集中的作用,并且CCR3在浸润性T淋巴细胞上的表达进一步支持了Th2细胞参与BP的发病机制。

相似文献

1
Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.大疱性类天疱疮中嗜酸性粒细胞趋化因子及其特异性受体CCR3的表达增加。
Eur J Dermatol. 2002 Jan-Feb;12(1):27-31.
2
Interleukin-16 expression and release in bullous pemphigoid.大疱性类天疱疮中白细胞介素-16的表达与释放
Clin Exp Immunol. 2004 Sep;137(3):595-600. doi: 10.1111/j.1365-2249.2004.02570.x.
3
Serum chemokine profile in patients with bullous pemphigoid.大疱性类天疱疮患者的血清趋化因子谱
Br J Dermatol. 2007 Mar;156(3):454-9. doi: 10.1111/j.1365-2133.2006.07601.x.
4
CCL18 is expressed in patients with bullous pemphigoid and parallels disease course.CCL18在大疱性类天疱疮患者中表达,并与疾病进程平行。
Br J Dermatol. 2009 Apr;160(4):747-55. doi: 10.1111/j.1365-2133.2008.08979.x. Epub 2008 Dec 15.
5
Eotaxin and CCR3 are up-regulated in exacerbations of chronic bronchitis.在慢性支气管炎急性加重期,嗜酸性粒细胞趋化因子和CCR3表达上调。
Allergy. 2002 Jan;57(1):17-22.
6
Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.他克莫司可降低特应性皮炎中嗜酸性粒细胞趋化因子、CCR3、RANTES和白细胞介素-5的表达。
Br J Dermatol. 2005 Jun;152(6):1173-81. doi: 10.1111/j.1365-2133.2005.06474.x.
7
Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.只有在白细胞介素-2和白细胞介素-4共同诱导嗜酸性粒细胞趋化因子表达CCR3时,它才会激活T细胞使其产生趋化作用和黏附作用。
J Immunol. 1999 Apr 1;162(7):4285-92.
8
Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.嗜酸性粒细胞性食管炎中适应性Th2免疫与嗜酸性粒细胞趋化因子-3/C-C趋化因子受体3的相互作用
J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):22-31. doi: 10.1097/MPG.0b013e318043c097.
9
Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.寻常型天疱疮和类天疱疮患者血清及疱液中白细胞介素10的存在情况。
Cytokine. 2000 Jul;12(7):1076-83. doi: 10.1006/cyto.1999.0642.
10
High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.大疱性类天疱疮患者水疱液和血清中胸腺与激活调节趋化因子水平升高。
Br J Dermatol. 2003 Feb;148(2):203-10. doi: 10.1046/j.1365-2133.2003.05066.x.

引用本文的文献

1
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.大疱性类天疱疮中的IgG自身抗体在角质形成细胞中诱导致病性的依赖MyD88的促炎反应。
Nat Commun. 2025 Aug 6;16(1):7254. doi: 10.1038/s41467-025-62495-2.
2
Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine.大疱性类天疱疮的全身影响:连接皮肤科与内科
Diagnostics (Basel). 2024 Oct 12;14(20):2272. doi: 10.3390/diagnostics14202272.
3
Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review).
大疱性类天疱疮的病理生理学:2 型炎症的作用和新兴治疗策略(叙述性评论)。
Adv Ther. 2024 Dec;41(12):4418-4432. doi: 10.1007/s12325-024-02992-w. Epub 2024 Oct 19.
4
Eosinophils in Oral Disease: A Narrative Review.口腔疾病中的嗜酸性粒细胞:一篇叙述性综述。
Int J Mol Sci. 2024 Apr 16;25(8):4373. doi: 10.3390/ijms25084373.
5
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.大疱性类天疱疮治疗的进展:全面的药物研发管线更新。
Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29.
6
The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.Eotaxin-1/CCR3 轴和基质金属蛋白酶-9 在抗 NC16A IgE 诱导的大疱性类天疱疮中至关重要。
J Immunol. 2023 Oct 15;211(8):1216-1223. doi: 10.4049/jimmunol.2300080.
7
Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches.靶向大疱性类天疱疮中的2型炎症:当前及新兴治疗方法
Front Med (Lausanne). 2023 Aug 8;10:1196946. doi: 10.3389/fmed.2023.1196946. eCollection 2023.
8
Bullous pemphigoid-What do we know about the most recent therapies?大疱性类天疱疮——我们对最新疗法了解多少?
Front Med (Lausanne). 2022 Nov 3;9:1057096. doi: 10.3389/fmed.2022.1057096. eCollection 2022.
9
The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.IgE 自身抗体与嗜酸性粒细胞在大疱性类天疱疮发病机制中的交汇。
Front Immunol. 2019 Oct 4;10:2331. doi: 10.3389/fimmu.2019.02331. eCollection 2019.
10
The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.嗜酸性粒细胞在大疱性类天疱疮中的作用:黏膜皮肤疾病中嗜酸性粒细胞致病性的发展模型
Front Med (Lausanne). 2018 Jul 10;5:201. doi: 10.3389/fmed.2018.00201. eCollection 2018.